Compass Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 16.81 M | $58.84 M | 24.57% | 12.16% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 15.22 M | $53.27 M | 0.00% | 11.01% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 14.10 M | $49.35 M | 97.23% | 10.20% |
| BLACKSTONE INC. | 11/14/2025 | 9.84 M | $34.44 M | -1.85% | 7.12% |
| VIVO CAPITAL, LLC | 11/14/2025 | 9.55 M | $33.41 M | 57.95% | 6.90% |
| ENAVATE SCIENCES GP, LLC | 11/14/2025 | 7.79 M | $27.26 M | 0.00% | 5.63% |
| BLACKROCK, INC. | 11/12/2025 | 7.37 M | $25.80 M | 14.93% | 5.33% |
| VANGUARD GROUP INC | 11/07/2025 | 7.06 M | $24.72 M | 45.62% | 5.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 5.19 M | $18.15 M | 17.21% | 3.75% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 5.08 M | $17.77 M | -9.72% | 3.67% |
| BVF INC/IL | 11/14/2025 | 4.75 M | $16.63 M | 100.00% | 3.44% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 4.47 M | $15.66 M | -9.84% | 3.24% |
| FMR LLC | 11/13/2025 | 4.14 M | $14.48 M | 0.07% | 2.99% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 3.24 M | $11.33 M | 280.35% | 2.34% |
| STATE STREET CORP | 11/14/2025 | 3.11 M | $10.87 M | 57.58% | 2.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.94 M | $10.31 M | 26.96% | 2.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.83 M | $9.92 M | 126.76% | 2.05% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 2.83 M | $9.89 M | 100.00% | 2.04% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/12/2025 | 2.59 M | $9.07 M | 0.00% | 1.87% |
| RTW INVESTMENTS, LP | 11/14/2025 | 2.50 M | $8.75 M | 100.00% | 1.81% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 2.05 M | $7.18 M | 100.00% | 1.48% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 2.03 M | $7.10 M | 100.00% | 1.47% |
| JPMORGAN CHASE & CO | 11/26/2025 | 2.00 M | $7.00 M | -5.95% | 1.45% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.70 M | $5.95 M | 1,025.38% | 1.23% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2025 | 1.25 M | $4.38 M | 657.58% | 0.90% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.04 M | $3.64 M | 793.59% | 0.75% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.00 M | $3.50 M | 100.00% | 0.72% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 946.66 K | $3.31 M | 79.75% | 0.68% |
| BIRCHVIEW CAPITAL, LP | 11/13/2025 | 872.94 K | $3.06 M | 100.00% | 0.63% |
| NORTHERN TRUST CORP | 11/14/2025 | 861.94 K | $3.02 M | 17.32% | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2025 | 840.09 K | $2.94 M | 100.00% | 0.61% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 11/14/2025 | 700.00 K | $2.45 M | 100.00% | 0.51% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 476.29 K | $1.67 M | 100.00% | 0.34% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 335.25 K | $1.17 M | 22.59% | 0.24% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 318.12 K | $1.11 M | -8.60% | 0.23% |
| NUVEEN, LLC | 11/12/2025 | 259.21 K | $907.24 K | 0.00% | 0.19% |
| CITADEL ADVISORS LLC | 11/14/2025 | 233.27 K | $816.45 K | 100.00% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 223.18 K | $781.12 K | 5.68% | 0.16% |
| BARCLAYS PLC | 11/12/2025 | 222.42 K | $778.46 K | -7.99% | 0.16% |
| UBS GROUP AG | 11/13/2025 | 198.27 K | $693.95 K | -24.76% | 0.14% |
| MORGAN STANLEY | 11/14/2025 | 186.95 K | $654.33 K | -24.84% | 0.14% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 175.56 K | $618.80 K | 1.93% | 0.13% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 154.17 K | $539.60 K | -78.75% | 0.11% |
| CM MANAGEMENT, LLC | 11/13/2025 | 150.00 K | $525.00 K | 100.00% | 0.11% |
| SG AMERICAS SECURITIES, LLC | 10/23/2025 | 149.31 K | $523.00 K | -59.94% | 0.11% |
| RHUMBLINE ADVISERS | 11/06/2025 | 139.31 K | $487.59 K | 22.76% | 0.10% |
| ATOM INVESTORS LP | 11/14/2025 | 106.67 K | $373.36 K | 100.00% | 0.08% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 104.16 K | $364.56 K | -10.72% | 0.08% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 95.79 K | $335.25 K | 14.17% | 0.07% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 87.85 K | $307.49 K | 322.92% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Compass Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 139 institutional investors and hedge funds held shares of Compass Therapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 16.81 M
ORBIMED ADVISORS LLC: 15.22 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 14.1 M
Blackstone Inc.: 9.84 M
Vivo Capital, LLC: 9.55 M
Enavate Sciences GP, LLC: 7.79 M
109.23% of Compass Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 162.37 M shares in the last 24 months. This purchase volume represents approximately $899.53 M in transactions.